Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04110132 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Postoperative Analgesia Using Ganglion Impar Block After Anal Surgery

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Dec 31, 2024 to Dec 31, 2029
    • Start date: Jul 1, 2024 to Jul 1, 2028
    • Study sites: 1 to 0
    v6
  2. Primary and study completion dates: Dec 31, 2022 to Dec 31, 2024
    • Start date: Jul 1, 2022 to Jul 1, 2024
    v5
  3. Primary and study completion dates: Dec 31, 2021 to Dec 31, 2022
    • Start date: Jul 1, 2021 to Jul 1, 2022
    v4
  4. Primary and study completion dates: Dec 31, 2020 to Dec 31, 2021
    • Start date: Jul 1, 2020 to Jul 1, 2021
    v3
  5. Start date: Dec 1, 2019 to Jul 1, 2020
    • Primary completion date: Jul 31, 2020 to Dec 31, 2020
    • Study completion date: Oct 31, 2020 to Dec 31, 2020
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this study is to evaluate the ganglion Impar block in the prevention of postoperative pain after anal surgery.
Trial Details
NCT Number NCT04110132
Lead Sponsor University of Alexandria
Conditions
(from sponsor)		 Postoperative Pain
Related terms Postoperative Pain
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov